A deletion in chromosome 11q may predict the response to anthracycline-based chemotherapy in patients with early node-negative breast cancer

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome

By Le Morvan Valéérie   Smith Denis   Laurand Armelle   Brouste Vééronique   Bellott Ricardo   Soubeyran Isabelle   Mathoulin-Pelissier Simone   Robert Jacques  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1693-1703

Future Medicine

Access to resources Recommend Favorite

Taxanes in the Adjuvant Treatment of Breast Cancer

By Trauth Donna   Goldstein Lori J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 222-231

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Change in Cycle 1 to Cycle 2 Haematological Counts Predicts Toxicity in Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy

By Hurria Arti   Brogan Kelly   Panageas Katherine S.   Jakubowski Ann   Zauderer Marjorie   Pearce Carol   Norton Larry   Howard Jane   Hudis Clifford  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 709-715

Adis International

Access to resources Recommend Favorite

Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer

By Heys Steven D   Sarkar Tarun   Hutcheon Andrew W  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2147-2157

Informa Healthcare

Access to resources Recommend Favorite